identification of synthetically chemotherapeutic substances able to inhibit, delay, or reverse the process of carcinogenesis in several stages. The target compounds presenting two regions for SAR evaluation were screened for their activity toward MDA-MB-241 breast cancer cell proliferation for the first time. Compound (1E, 2E)-1,2-bis(1-(3-nitrophenyl)ethylidene) hydrazine (L6) showed significant inhibitory
以
乙醚为溶剂,
乙酸为催化剂,在温和条件下(室温,3天),通过各种醛/酮化合物与
肼的一锅缩合反应,设计了一系列对称的席夫碱衍
生物(L1-L7)。目标产物通过 H-1 和 C-13 NMR、FT-IR 和
液相色谱质谱 (LC/MS) 进行表征和分析。我们的研究重点是鉴定能够在几个阶段抑制、延迟或逆转致癌过程的合成
化学治疗物质。首次筛选了呈现两个区域用于
SAR 评估的目标化合物对
MDA-MB-241 乳腺癌细胞增殖的活性。化合物 (1E, 2E)-1,2-双(1-(3-
硝基苯基)亚乙基)
肼 (L6) 显示出显着的抑制活性 (IC50 = 7)。